tryptophan and Carcinoma, Ductal, Breast

tryptophan has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balbín, M; Ferrando, AA; Fueyo, A; Hannon, GJ; López-Otín, C; Pendás, AM; Vizoso, F1

Other Studies

1 other study(ies) available for tryptophan and Carcinoma, Ductal, Breast

ArticleYear
Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.
    The Journal of biological chemistry, 1996, Jun-28, Volume: 271, Issue:26

    Topics: Arginine; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; Humans; Molecular Sequence Data; Oncogene Proteins; Point Mutation; Protein Binding; Structure-Activity Relationship; Tryptophan

1996